Here are what the editors at HealthDay consider to be the most important developments in Dermatology for March 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice.
Novel Interstitium Has Been Identified in Human Tissues
THURSDAY, March 29, 2018 (HealthDay News) — A previously unrecognized interstitium has been identified in human tissues, according to a study published online March 27 in Scientific Reports.
EHR Usability Contributes to Possible Patient Harm Events
TUESDAY, March 27, 2018 (HealthDay News) — Electronic health record (EHR) usability may contribute to possible patient harm events, according to a research letter published in the March 27 issue of the Journal of the American Medical Association.
Abstract/Full Text (subscription or payment may be required)
Ethical Duties ID’d for Short-Term Global Health Experiences
MONDAY, March 26, 2018 (HealthDay News) — In a position paper published online March 27 in the Annals of Internal Medicine, ethical obligations have been detailed for physicians participating in short-term global health experiences (STEGHs).
Vascular Malformations Contribute to Lower Quality of Life
FRIDAY, March 23, 2018 (HealthDay News) — Patients with vascular malformations (VAMs) have increased pain and psychosocial distress, compared with the general U.S. population, according to a review published online March 21 in JAMA Dermatology.
Abstract/Full Text
Editorial (subscription or payment may be required)
Lean Approach May Help Tackle Burnout in Health Care Providers
FRIDAY, March 23, 2018 (HealthDay News) — The Lean approach, which emphasizes reducing waste and improving customer value by focusing on the big picture, can be used to address physician burnout, according to a report published in Medical Economics.
Microneedling + 5-Fluorouracil Effective Vitiligo Treatment
THURSDAY, March 22, 2018 (HealthDay News) — Microneedling in combination with 5-fluorouracil is a safe and effective treatment for vitiligo, according to a study published online March 12 in the Journal of Cosmetic Dermatology.
Abstract/Full Text (subscription or payment may be required)
Unique Risks Associated With Texting Medical Orders
THURSDAY, March 22, 2018 (HealthDay News) — Despite the popularity, convenience, and speed of texting medical orders, there are unique and alarming risks associated with the practice, according to a report published in Drug Topics.
Hydrochlorothiazide Tied to Non-Melanoma Skin Cancer Risk
THURSDAY, March 22, 2018 (HealthDay News) — Use of the diuretic hydrochlorothiazide is associated with a substantially increased risk of non-melanoma skin cancer, according to a study published in the April issue of the Journal of the American Academy of Dermatology.
Blueprint Being Developed to Address Physician Burnout
Freshwater Swimming Tied to Stomach Bugs, Skin Conditions 
Considerable Global Disparities Found in Access to Dermatological Care 
Extreme Heat Linked to 33 Clinically Reportable Diagnoses 
Psoriasis Linked to Impairment of Some Sleep Domains 
Burden of Myocardial Dysfunction Elevated for Individuals With Psoriasis 
Dose Reduction of Biologics Effective, Safe for Psoriasis .jpg)
